Technology · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Quanterix Corp (QTRX) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores QTRX at 19.7/100 on a 32-signal composite quality model, placing it at rank #2,787 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (3.4) and balance sheet strength (6.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 11.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Quanterix Corp reports quarterly revenue of $32.9M, net income of $-48.9M, free cash flow of $-5.2M. Top institutional holders of QTRX by reported 13-F value include BlackRock, Blue Water Life Science Advisors, First Eagle Investment Management, based on the most recent SEC filings. QTRX trades on the Nasdaq exchange and files with the SEC under CIK 1503274. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate QTRX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Quanterix Corp directly from SEC EDGAR.
AI Quality Score
19.7/100
AI Rank
#2,787
Revenue
$32.9M
Net Income
$-48.9M
Free Cash Flow
$-5.2M
| Period | Form | Revenue | Net income | Operating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $138.9M | $-107.2M | -90.4% |
| FY 2024 | 10-K | $137.4M | $-38.5M | -38.3% |
| FY 2023 | 10-K/A | $122.4M | $-28.4M | -37.6% |
| FY 2022 | 10-K/A | $105.5M | $-99.6M | -98.8% |
| FY 2021 | 10-K/A | $110.6M | $-55.5M | -51.1% |
| FY 2020 | 10-K/A | $86.4M | $-31.5M | -36.6% |
| Institution | Shares | Value | Reported |
|---|---|---|---|
| BlackRock | 3,635,411 | $15.7M | 2026-06-30 |
| Blue Water Life Science Advisors | 3,474,202 | $15.0M | 2026-06-30 |
| First Eagle Investment Management | 2,753,165 | $11.9M | 2026-06-30 |
| Portolan Capital Management | 1,899,308 | $8.2M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT | 1,800,644 | $7.8M | 2026-06-30 |
| Lionhunter Capital Management | 1,500,427 | $6.5M | 2026-06-30 |
| AQR CAPITAL MANAGEMENT | 1,343,005 | $5.8M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT | 1,131,377 | $4.9M | 2026-06-30 |
| AMERIPRISE FINANCIAL | 987,424 | $4.3M | 2026-06-30 |
| MARSHALL WACE, LLP | 973,872 | $4.2M | 2026-06-30 |
13F Pro Quality Score
Rank #2,787 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk